Of 807 clinical trials approved by the European Medicines Agency, 77% disclosed their results within a year of completion or of regulatory approval –- a figure that rose to 89% by January 2013, according to a study by the Association of the British Pharmaceutical Industry. "[W]e fully expect to see the trend towards greater transparency continue on this positive trajectory," said ABPI chief executive Stephen Whitehead. The study appeared in the journal Current Medical Research and Opinion.

Full Story:
PharmaTimes (U.K.)

Related Summaries